Get the Stockscreener App
0.00
100.00%
-1.01
Procaps Group S A stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
See More
Previous Close:
$1.01
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$113.95M
Revenue:
$414.10M
Net Income/Loss:
$52.20M
P/E Ratio:
0.00
EPS:
0.52
Net Cash Flow:
$34.06M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.775
Procaps Group S A Stock (PROC) Company Profile
Compare PROC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROC
Procaps Group S A
|
0.00 | 113.95M | 414.10M | 52.20M | 34.06M | 0.52 |
|
ZTS
Zoetis Inc
|
150.91 | 65.46B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.18 | 46.11B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.84B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.29 | 16.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.46 | 12.81B | 2.76B | 1.11B | 898.10M | 22.77 |
Procaps Group S A Stock (PROC) Latest News
Procaps Group Completes $90 Million Equity Raise and Note Conversion - TipRanks
Procaps Group S.A. announced that it has received $130 million in funding from Hoche Partners Pharma Holding S.a., Becaril S.A., Chemo Project S.A., Flying Fish Ventures Limited Partnership, Saint Thomas Commercial, S.A., Santana S.A. and other investor - MarketScreener
Procaps Group S.A. announced that it expects to receive $40 million in funding from Hoche Partners Pharma Holding S.a., Becaril S.A., Chemo Project S.A., Flying Fish Ventures Limited Partnership, Saint Thomas Commercial, S.A., Santana S.A. and other inve - marketscreener.com
Procaps Group Completes $130 Million Capital Raise and Debt Restructuring - TipRanks
Procaps Group Secures $130 Million in Equity Investment and - GlobeNewswire
$130M Investment Transforms Procaps: New Leadership Takes Control in Strategic Overhaul - Stock Titan
Procaps Group (NASDAQ:PROC) Stock Price Down 40.3% – Time to Sell? - Defense World
Procaps Group Plans Extraordinary Meeting to Address Financial Strategies - TipRanks
Procaps Group (NASDAQ:PROC) vs. Viracta Therapeutics (NASDAQ:VIRX) Financial Comparison - Defense World
Nasdaq delists Colombia’s Procaps Group due to financial shortfalls - Invezz
Procaps Group S.A (PROC) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Balance Sheet Insights: Procaps Group S.A (PROC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Procaps Group Receives Delisting Notice From Nasdaq - GlobeNewswire
Procaps Group Gets Nasdaq Delisting Notice; Shares Down Pre-Bell -February 03, 2025 at 09:29 am EST - Marketscreener.com
Pharma Giant Procaps Delisted from Nasdaq: Key Details on Trading Migration - StockTitan
Procaps Group Faces Additional Nasdaq Delinquency Notice - TipRanks
Procaps Group Receives Additional Delinquency Letter - The Manila Times
Procaps Group Faces New Nasdaq Delinquency Notice Over Missing Financial Statements - StockTitan
Ironwood Pharmaceuticals (IRWD) Stock Drops Amid Industry Activi - GuruFocus
Procaps Group Appoints Interim CFO and Secures $40M Funding - TipRanks
Procaps Group S.A. Appoints Daniel Bernal as the Interim Chief Financial Officer - Marketscreener.com
Procaps Group S.A. (NASDAQ:PROC) Sees Large Decrease in Short Interest - Defense World
Procaps Group S.A. (NASDAQ:PROC) Sees Large Decline in Short Interest - MarketBeat
Procaps Group Announces Corporate Structure and Strategic Investment Framework - TipRanks
Procaps Group announces newly appointed board members, CFO transition - MSN
Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates - GlobeNewswire
Procaps Group, S.A. Announces Patricio Vargas Transition from the Role of Chief Financial Officer to Chief Optimization and Rationalization Officer - Marketscreener.com
A Look At The Intrinsic Value Of Procaps Group S.A. (NASDAQ:PROC) - Yahoo Finance
Wall Street Holiday: Nasdaq, NYSE to remain closed on these days in December - MSN
Auckland airport shares worth $773 million on the block, term sheet shows - Yahoo Canada Finance
Wells Fargo to move headquarters in San Francisco, source says - Yahoo Canada Finance
Procaps Group Announces Financing, Shareholders Agreement and Board Updates - GlobeNewswire
Procaps Group Secures $40M Financing Deal, Announces Major Board Restructuring | PROC Stock News - StockTitan
Campbell's falls short of sales estimates, names insider Beekhuizen as CEO - Yahoo Canada Finance
Manitoba government promises trade office in U.S. capital to boost economy - Yahoo Canada Finance
Procaps Group, S.A. Announces Resignation of Board Members - Marketscreener.com
Procaps Group Announces Shareholder Meetings Amid Financial Scrutiny - TipRanks
Procaps Group S.A. announced that it expects to receive $20 million in funding from Hoche Partners Pharma Holding S.a. - Marketscreener.com
Ironwood Pharmaceuticals (IRWD) Stock Surges Amid Strong Financi - GuruFocus.com
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket - Inkl
Insiders the biggest winners as Procaps Group S.A.'s (NASDAQ:PROC) market cap rises to US$125m - Simply Wall St
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket - Benzinga
Merck (MRK) Stock Surges Amid Industry Layoff Trends - GuruFocus.com
Amarin (AMRN) Stock Surges Amid Mixed Industry Performance - GuruFocus.com
Ironwood Pharmaceuticals (IRWD) Stock Declines Despite Industry Gains - GuruFocus.com
Procaps Group Faces Nasdaq Delisting Over Filing Delay By Investing.com - Investing.com Canada
Procaps Group Faces Nasdaq Delisting Over Filing Delay - Investing.com India
Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing - GlobeNewswire
Procaps Group Faces Nasdaq Delisting Risk Over Delayed 2023 Financial Filing | PROC Stock News - StockTitan
Procaps Group S A Stock (PROC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):